Malta - English - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - atazanavir sulfate - hard capsule - atazanavir sulfate 150 mg - antivirals for systemic use

Malta - English - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - atazanavir sulfate - hard capsule - atazanavir sulfate 300 mg - antivirals for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - atazanavir sulfate - capsule, hard - 300 milligram(s) - atazanavir

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - lamotrigine - oral tablet - 200mg

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atazanavir sulfate 170.85mg equivalent to atazanavir 150mg; atazanavir sulfate 170.85mg equivalent to atazanavir 150mg - capsule - 150 mg - active: atazanavir sulfate 170.85mg equivalent to atazanavir 150mg excipient: crospovidone gelatin   iron oxide red lactose monohydrate magnesium stearate patent blue v   purified water   tekprint black sw-9008 titanium dioxide   active: atazanavir sulfate 170.85mg equivalent to atazanavir 150mg excipient: brilliant blue fcf   crospovidone erythrosine gelatin iron oxide yellow lactose monohydrate magnesium stearate purified water   titanium dioxide   - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atazanavir sulfate 227.8mg equivalent to atazanavir 200mg; atazanavir sulfate 227.8mg equivalent to atazanavir 200mg - capsule - 200 mg - active: atazanavir sulfate 227.8mg equivalent to atazanavir 200mg excipient: brilliant blue fcf   crospovidone erythrosine gelatin   lactose monohydrate magnesium stearate purified water   titanium dioxide   active: atazanavir sulfate 227.8mg equivalent to atazanavir 200mg excipient: crospovidone gelatin   indigo carmine iron oxide yellow lactose monohydrate magnesium stearate patent blue v purified water   tekprint black sw-9008 titanium dioxide   - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atazanavir sulfate 341.7mg equivalent to atazanavir 300mg; atazanavir sulfate 341.7mg equivalent to atazanavir 300mg - capsule - 300 mg - active: atazanavir sulfate 341.7mg equivalent to atazanavir 300mg excipient: brilliant blue fcf crospovidone erythrosine gelatin   iron oxide red iron oxide yellow lactose monohydrate magnesium stearate purified water   titanium dioxide   active: atazanavir sulfate 341.7mg equivalent to atazanavir 300mg excipient: crospovidone gelatin   iron oxide red   iron oxide yellow lactose monohydrate magnesium stearate patent blue v purified water   tekprint black sw-9008 titanium dioxide   - atazanavir viatris is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents, in adult patients and in paediatric patients 6 to 18 years of age. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - pazopanib hydrochloride - film-coated tablet - antineoplastic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - atazanavir sulfate 170.872mg (equiv 150 mg atazanavir) - capsule - 150 mg - active: atazanavir sulfate 170.872mg (equiv 150 mg atazanavir) excipient: crospovidone gelatin indigo carmine lactose monohydrate magnesium stearate titanium dioxide - atazanavir is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - atazanavir sulfate 227.829mg (equiv 200 mg atazanavir) - capsule - 200 mg - active: atazanavir sulfate 227.829mg (equiv 200 mg atazanavir) excipient: crospovidone gelatin indigo carmine lactose monohydrate magnesium stearate titanium dioxide - atazanavir is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies.